SHEENA MCGUFFEY: Open Payments
NPI 1609548965 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 24 payments from 18 companies in 2025. Trend: 2023 $873 · 2024 $1,609 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| BETA BIONICS, INC. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, REXULTI, TRELEGY ELLIPTA, Auvelity, JARDIANCE, iLet Bionic Pancreas, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
